Quantum量子訊息有限公司
← 最新全球產業報告

Prurigo Nodularis Therapeutics Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-07-10 · 259 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 1,550 Mn
2033 年預估規模
USD 2,050 Mn
年複合成長率 CAGR
4.1%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-07-10頁數 259報告編號 CMI4509

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Prurigo Nodularis Therapeutics Market, By Product Type (Corticosteroids, Capsaicin Cream, Antihistamines, Anticonvulsants, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Prurigo Nodularis is skin disease that causes hard and itchy lumps on skin, which usually appears on the arms or legs. Prurigo nodularis is a rare disease and currently, the treatment of the disease is still in research and development process. Treatments may include topical, oral, and intralesional corticosteroids; phototherapy; antihistamines; anxiolytics; opiate receptor antagonists; and thalidomide. Market Dynamics Key players are focusing on product approvals to strengthen their position in the global Prurigo nodularis therapeutics market. For instance, in October 2020, Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to its Vixarelimab drug for the treatment of pruritus associated with prurigo nodularis. Key features of the study • This report provides in-depth analysis of the global prurigo nodularis therapeutics market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global prurigo nodularis therapeutics market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies • Key companies covered as a part of this study include Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Services, Inc., Sanofi SA, Takeda Pharmaceutical Company Limited, Novartis AG, Celgene Corporation, VYNE Therapeutics Inc., Trevi Therapeutics Inc., Galderma SA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Merck & Co. Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics. • The global Prurigo nodularis therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prurigo nodularis therapeutics market. Market Segmentation • By Product Type (Revenue, USD Mn, 2021-2033) o Corticosteroids o Capsaicin Cream o Antihistamines o Anticonvulsants o Others • By Distribution Channel (Revenue, USD Mn, 2021-2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Region (Revenue, USD Mn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Bayer AG o GlaxoSmithKline Plc. o Johnson & Johnson Services, Inc. o Sanofi SA o Takeda Pharmaceutical Company Limited o Novartis AG o Celgene Corporation o VYNE Therapeutics Inc. o Trevi Therapeutics Inc. o Galderma SA o Pfizer Inc. o Teva Pharmaceutical Industries Ltd. o Merck & Co. Inc
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Disease Type Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Global Prurigo Nodularis Therapeutics Market, By Product Type, 2021 – 2033, (USD Million) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Corticosteroids  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) o Capsaicin Cream  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) o Antihistamines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) o Anticonvulsants  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) 5. Global Prurigo Nodularis Therapeutics Market, By Distribution Channel, 2021 – 2033, (USD Million) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million) 6. Global Prurigo Nodularis Therapeutics Market, By Region, 2021 – 2033, (USD Million) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Million) o North Africa o Central Africa o South Africa 7. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  Bayer AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  GlaxoSmithKline Plc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Johnson & Johnson Services, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Sanofi SA o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Takeda Pharmaceutical Company Limited o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Novartis AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Celgene Corporation o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  VYNE Therapeutics Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Trevi Therapeutics Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Galderma SA o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Pfizer Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Teva Pharmaceutical Industries Ltd. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Merck & Co. Inc o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 8. Section o References o Research Methodology o About Us

提及公司

Bayer AGGlaxoSmithKline Plc.Johnson & Johnson Services, Inc.Sanofi SATakeda Pharmaceutical Company LimitedNovartis AGCelgene CorporationVYNE Therapeutics Inc.Trevi Therapeutics Inc.Galderma SAPfizer Inc.Teva Pharmaceutical Industries Ltd.Merck & Co. Inc

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們